Cargando…

Correction to: TIM-3: a tumor-associated antigen beyond checkpoint inhibition?

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10569373/ https://www.ncbi.nlm.nih.gov/pubmed/37841366 http://dx.doi.org/10.1093/immadv/ltad018

Ejemplares similares

TIM-3: a tumor-associated antigen beyond checkpoint inhibition?
por: Barth, Stefan, et al.
Publicado: (2022)

Correction: Tim-3 Expression in Cervical Cancer Promotes Tumor Metastasis
por: Cao, Yang, et al.
Publicado: (2016)

Correction: Targeting LAG-3, TIM-3, and TIGIT for cancer immunotherapy
por: Cai, Letong, et al.
Publicado: (2023)

Correction: Tim-3 protects against cisplatin nephrotoxicity by inhibiting NF-κB-mediated inflammation
por: Li, Peiyao, et al.
Publicado: (2023)

Correction to: Inhibition of T cell immunoglobulin and mucin-1 (TIM-1) protects against cerebral ischemia-reperfusion injury
por: Zheng, Yueying, et al.
Publicado: (2019)

Correction: Glycan Elongation Beyond the Mucin Associated Tn Antigen Protects Tumor Cells from Immune-Mediated Killing
por: Madsen, Caroline B., et al.
Publicado: (2013)

Correction: Lymphoma endothelium preferentially expresses Tim-3 and facilitates the progression of lymphoma by mediating immune evasion
por: Huang, Xiaoyuan, et al.
Publicado: (2021)

Correction to: Characterization of sabatolimab, a novel immunotherapy with immuno-myeloid activity directed against TIM-3 receptor
Publicado: (2023)

TIM-3 in Leukemia; Immune Response and Beyond
por: Rezaei, Mahnaz, et al.
Publicado: (2021)

Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity
por: Sakuishi, Kaori, et al.
Publicado: (2011)

Correction: High levels of chromosomal aberrations negatively associate with benefit to checkpoint inhibition in NSCLC
Publicado: (2022)

Correction: Drosophila TIM Binds Importin α1, and Acts as an Adapter to Transport PER to the Nucleus
Publicado: (2015)

Correction: MRI of tumor T cell infiltration in response to checkpoint inhibitor therapy
Publicado: (2020)

Correction: Immune Checkpoint Inhibitor-Associated Colitis and Hepatitis
por: Reddy, Haritha G., et al.
Publicado: (2018)

Correction: Immune checkpoint inhibitor-associated celiac disease
Publicado: (2020)

Correction to: PML: Regulation and multifaceted function beyond tumor suppression
por: Hsu, Kuo-Sheng, et al.
Publicado: (2018)

Correction: Methamphetamine Inhibits Antigen Processing, Presentation, and Phagocytosis
por: Tallóczy, Zsolt, et al.
Publicado: (2008)

TIM-3 Is a Potential Immune Checkpoint Target in Cats with Mammary Carcinoma
por: Valente, Sofia, et al.
Publicado: (2023)

Correction: Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition
Publicado: (2021)

Correction: Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition
Publicado: (2022)

Author Correction: Histone acetyltransferease p300 modulates TIM4 expression in dendritic cells
por: Yang, Bo, et al.
Publicado: (2021)

TIM4 expression by dendritic cells mediates uptake of tumor-associated antigens and anti-tumor responses
por: Caronni, Nicoletta, et al.
Publicado: (2021)

Correction to: Fibroblast growth factor receptor 3 alterations and response to immune checkpoint inhibition in metastatic urothelial cancer: a real world experience
por: Rose, Tracy L., et al.
Publicado: (2022)

Correction: Chronic immune checkpoint inhibitor pneumonitis
Publicado: (2020)

Association of TIM-3 checkpoint receptor expression on T cells with treatment-free remission in chronic myeloid leukemia
por: Irani, Yazad D., et al.
Publicado: (2023)

Tim-3 adaptor protein Bat3 is a molecular checkpoint of T cell terminal differentiation and exhaustion
por: Zhu, Chen, et al.
Publicado: (2021)

Correction: Efficacy of immune checkpoint inhibitors for in-transit melanoma
Publicado: (2020)

Correction: T lymphocyte-targeted immune checkpoint modulation in glioma
Publicado: (2020)

Tim-3 is upregulated in human colorectal carcinoma and associated with tumor progression
por: Yu, Muming, et al.
Publicado: (2017)

Author Correction: Role of Tim4 in the regulation of ABCA1(+) adipose tissue macrophages and post-prandial cholesterol levels
por: Magalhaes, M. S., et al.
Publicado: (2022)

Correction: TRAF3–EWSR1 signaling axis acts as a checkpoint on germinal center responses
por: Li, Yanchuan, et al.
Publicado: (2023)

Tim1 and Tim3 are not essential for experimental allergic asthma
por: Barlow, J L, et al.
Publicado: (2011)

Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen–specific CD8(+) T cell dysfunction in melanoma patients
por: Fourcade, Julien, et al.
Publicado: (2010)

Correction: Early decrease of blood myeloid-derived suppressor cells during checkpoint inhibition is a favorable biomarker in metastatic melanoma
Publicado: (2023)

Correction: Mps1(Mph1) Kinase Phosphorylates Mad3 to Inhibit Cdc20(Slp1)-APC/C and Maintain Spindle Checkpoint Arrests
por: Zich, Judith, et al.
Publicado: (2016)

Correction: On the mechanism of anti-CD39 immune checkpoint therapy
Publicado: (2020)

Correction: Inhibiting DNA methylation activates cancer testis antigens and expression of the antigen processing and presentation machinery in colon and ovarian cancer cells
por: Siebenkäs, Cornelia, et al.
Publicado: (2020)

Correction: Chaudhuri et al. Diverse Functions of Tim50, a Component of the Mitochondrial Inner Membrane Protein Translocase. Int. J. Mol. Sci. 2021, 22, 7779
por: Chaudhuri, Minu, et al.
Publicado: (2022)

Immune Checkpoint Profiling in Humanized Breast Cancer Mice Revealed Cell-Specific LAG-3/PD-1/TIM-3 Co-Expression and Elevated PD-1/TIM-3 Secretion
por: Bruss, Christina, et al.
Publicado: (2023)

Correction: Clinical characteristics, time course, treatment and outcomes of patients with immune checkpoint inhibitor-associated myocarditis
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qnanitdhq8tsrc0be4flju6jce